Lab mice displaying improved social behaviors after nutrient blend treatment, with scientists examining brain scans in a Taiwanese research facility.
Lab mice displaying improved social behaviors after nutrient blend treatment, with scientists examining brain scans in a Taiwanese research facility.
AI에 의해 생성된 이미지

Simple nutrient blend improves autism‑related behaviors in mouse models

AI에 의해 생성된 이미지
사실 확인됨

Researchers in Taiwan report that a low-dose combination of zinc, serine, and branched-chain amino acids improves neural function and social behaviors across several mouse models of autism spectrum disorder. The nutrient mix, which appears to act synergistically, restores more typical synaptic protein patterns and reduces excessive activity in the amygdala, according to a study in PLOS Biology.

A research team led by Tzyy-Nan Huang and Ming-Hui Lin at Academia Sinica in Taiwan tested a nutrient mixture on mouse models exhibiting autism-like traits. The study, published on December 2 in the open-access journal PLOS Biology, examined synapse-related proteins, amygdala activity using calcium imaging, and social behaviors in the animals.

Working with three autism spectrum disorder (ASD) mouse models, the scientists found that a combined low-dose supplementation of zinc, serine, and branched-chain amino acids shifted synaptic protein expression in autistic mice toward patterns seen in typical mice. The mixture also reduced abnormal neuronal hyperactivity in the amygdala, a brain region involved in emotion and social behavior, as reported by PLOS and summarized by ScienceDaily and other outlets.

Behavioral tests showed that social interactions improved when the animals received the nutrient combination, whereas the same low doses of the individual nutrients given alone did not measurably change behavior. This pattern was reproduced in two additional ASD mouse models, indicating that the three nutrients need to act together to be effective at low doses.

Yi-Ping Hsueh, a senior author of the paper, highlighted the broader implications of the findings. “As hundreds of genes are implicated in autism, each with distinct molecular functions, a ‘one gene–one therapy’ approach is impractical for addressing the complexity of ASD. Our findings show that a low-dose nutrient mixture containing zinc, branched-chain amino acids (BCAAs), and serine—working synergistically to improve synaptic function and social behaviors across three ASD mouse models—offers a safer and more practical strategy for long-term, broad application, even beginning in childhood,” Hsueh said, according to PLOS.

First author Tzyy-Nan Huang noted that higher doses of individual nutrients have previously been shown to influence synaptic function, but that the low-dose combination proved distinctive in this study. “High doses of individual nutrient supplements such as zinc, branched-chain amino acids, and serine can improve synaptic function through different mechanisms, but low doses of any single nutrient alone are ineffective. It is exciting to see that combining these nutrients at low doses successfully restores synaptic proteomes and enhances social behaviors in three different mouse models of autism,” Huang said.

Co-first author Ming-Hui Lin reported that the effects on neural circuits emerged quickly. “I was thrilled to observe that just seven days of treatment with the nutrient mixture significantly modulated neuronal circuit activity and connectivity in real time. These results provide strong support for the beneficial effects of low-dose nutrient supplement combinations,” Lin said.

The authors and independent commentators have cautioned that the work was conducted entirely in mice and does not establish that the same nutrient mix would help people with autism. Experts have also noted that aspects of the experimental design, including repeated behavioral testing, could influence some of the observed effects, underscoring the need for replication and further studies in other models and eventually in humans.

According to the study and statements released by PLOS, the research was supported by grants from Academia Sinica and the National Science and Technology Council in Taiwan. The funders did not influence the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

사람들이 말하는 것

Discussions on X about the nutrient blend study are limited but positive, with users and professional accounts highlighting the synergistic effects of low-dose zinc, serine, and branched-chain amino acids in improving neural function and social behaviors in autism mouse models. Biotech news and scientists emphasize its promise as a safer multi-nutrient strategy, restoring synaptic patterns and reducing amygdala activity. No negative or skeptical reactions identified.

관련 기사

Illustration of nitric oxide signaling modifying TSC2 protein to activate mTOR pathway in autism models, based on Hebrew University study.
AI에 의해 생성된 이미지

Study links nitric oxide to mTOR overactivity in some autism-related models

AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨

Researchers at the Hebrew University of Jerusalem report that increased nitric oxide signaling can chemically modify the protein TSC2, reducing its levels and allowing the mTOR pathway to become overactive—a chain of events they say appears in laboratory models and in samples from some children diagnosed with autism spectrum disorder.

Researchers at Kindai University report that oral arginine, a common amino acid, suppresses amyloid‑β aggregation and its toxic effects in fruit fly and mouse models of Alzheimer’s disease. In treated animals, amyloid buildup fell, inflammation markers dropped, and behavioral performance improved, suggesting arginine could be a low‑cost candidate for drug repurposing.

AI에 의해 보고됨 사실 확인됨

Researchers at Brazil’s Federal University of ABC report a simple copper-chelating molecule that reduced beta-amyloid–linked pathology and improved memory in rats. The compound showed no detectable toxicity in preclinical tests and, based on computer modeling, is predicted to cross the blood–brain barrier. The team is seeking industry partners for clinical development.

Researchers at Ben-Gurion University have identified the protein SIRT6 as a key regulator of tryptophan metabolism in the brain, explaining how its loss leads to toxic byproducts in aging and diseased brains. The study reveals that declining SIRT6 shifts tryptophan toward harmful pathways, reducing protective neurotransmitters like serotonin and melatonin. Blocking a related enzyme showed potential for reversing brain damage in models.

AI에 의해 보고됨 사실 확인됨

Researchers report that reduced ATP signaling in the dorsal hippocampus of male mice, driven by changes in the protein connexin 43, can trigger both depression- and anxiety-like behaviors. The study, published in The Journal of Neuroscience, finds that chronic stress lowers extracellular ATP and connexin 43 levels, that experimentally reducing the protein induces similar behaviors even without stress, and that restoring it in stressed animals improves behavioral signs of distress.

Researchers have uncovered how amyloid beta and inflammation may both trigger synapse pruning in Alzheimer's disease through a common receptor, potentially offering new treatment avenues. The findings challenge the notion that neurons are passive in this process, showing they actively erase their own connections. Led by Stanford's Carla Shatz, the study suggests targeting this receptor could preserve memory more effectively than current amyloid-focused drugs.

AI에 의해 보고됨 사실 확인됨

University of Michigan researchers using fruit flies report that changes in sugar metabolism can influence whether injured neurons and their axons deteriorate or persist. The work, published in *Molecular Metabolism*, describes a context-dependent response involving the proteins DLK and SARM1 that can briefly slow axon degeneration after injury, a finding the team says could inform future strategies for neurodegenerative disease research.

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부